These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3362610)

  • 1. [Clinico-immunological characteristics of the measles vaccine process in frequently ill children].
    Lakotkina EA; Zheleznikova GF; Blagoslovenskiĭ GS; Cherniaeva TV; Vozniuk TI
    Pediatriia; 1988; (1):48-51. PubMed ID: 3362610
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vaccinal measles process in children during the manifestations of acute respiratory diseases].
    Sergeeva MV; Vorotyntseva NV; Titova NS
    Pediatriia; 1991; (10):57-61. PubMed ID: 1788003
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunological reactivity of children vaccinated with a live measles vaccine].
    Bolotovskiĭ VM; Titova NS; Zakharova TR; Vorotyntseva NV; Mushkova EM
    Vopr Virusol; 1983; 28(5):588-90. PubMed ID: 6659474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics of the clinical course of the post-vaccination period and the development of anti-measles immunity in children with allergic diseases].
    Kostinov MP; Balabolkin II; Igna'teva GV; Sadykova DK
    Pediatriia; 1989; (9):33-8. PubMed ID: 2587165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Possibilities of measles vaccination in children with counterindications and duration of preservation of postvaccinal immunity].
    Piriev GG; Liashchenko VA
    Pediatriia; 1990; (12):27-30. PubMed ID: 2075059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological response to primary and secondary measles vaccination among school-age children in Malatya, Turkey.
    Durmaz R; Yakinci C; Köroğlu M; Tekerekoğlu MS
    J Trop Pediatr; 1998 Apr; 44(2):120. PubMed ID: 9604604
    [No Abstract]   [Full Text] [Related]  

  • 7. Study of antibody titres after measles vaccination: fever within 7 days of vaccination and efficacy of booster doses.
    Egami T; Egami K; Tanoue A
    Arch Dis Child; 2008 Apr; 93(4):319-20. PubMed ID: 17488762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles vaccination in atopic dermatitis.
    Cherian T; John TJ
    Indian Pediatr; 1997 Jun; 34(6):555. PubMed ID: 9357215
    [No Abstract]   [Full Text] [Related]  

  • 9. Two studies on optimal timing for measles vaccination.
    Riedmann EM
    Hum Vaccin Immunother; 2013 Dec; 9(12):2499. PubMed ID: 24322739
    [No Abstract]   [Full Text] [Related]  

  • 10. [Measles vaccination in HIV infected children].
    Ołdakowska A; Marczyńska M
    Med Wieku Rozwoj; 2008; 12(2 Pt 2):675-80. PubMed ID: 19418943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rural Kenya: measles during pregnancy and early infancy.
    Arya SC; Agarwal N
    J Infect Dis; 2006 Jan; 193(1):165-6; author reply 166-7. PubMed ID: 16323147
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinico-immunological characteristics of measles in children vaccinated with a live measles vaccine].
    Smorodinova IP; Shikina ES
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1973; 42():102-8. PubMed ID: 4808371
    [No Abstract]   [Full Text] [Related]  

  • 13. Wiping out measles: when to vaccinate?
    Ratnam S; West R; Gadag V
    CMAJ; 1997 Apr; 156(7):979, 982. PubMed ID: 9099164
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison study of measles antibody between two doses vaccination at 9, 18 months and single dose at 9 months in children 4-6 years old.
    Techasena W; Wongwacharapiboon P; Terawanich S; Pattamadilok S
    J Med Assoc Thai; 2011 Mar; 94(3):309-15. PubMed ID: 21560838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
    Dilraj A; Sukhoo R; Cutts FT; Bennett JV
    Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of CD14 promoter variants on measles vaccine responses and vaccine failure in children from Australia and Mozambique.
    Clifford HD; Hayden CM; Khoo SK; Naniche D; Mandomando IM; Zhang G; Richmond P; Le Souëf PN
    Tissue Antigens; 2013 Dec; 82(6):420-2. PubMed ID: 24147858
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda.
    Mupere E; Karamagi C; Zirembuzi G; Grabowsky M; de Swart RL; Nanyunja M; Mayanja H
    Vaccine; 2006 May; 24(19):4111-5. PubMed ID: 16554111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological response to measles vaccination in poor communities.
    Bhaskaram P; Madhusudan J; Radhrakrishna KV; Raj S
    Hum Nutr Clin Nutr; 1986 Jul; 40(4):295-9. PubMed ID: 3744889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles vaccination of Thai infants by intranasal and subcutaneous routes: possible interference from respiratory infections.
    Simasathien S; Migasena S; Bellini W; Samakoses R; Pitisuttitham P; Bupodom W; Heath J; Anderson L; Bennett J
    Vaccine; 1997 Feb; 15(3):329-34. PubMed ID: 9139495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.